CD Diagnostics – Trademark Portfolio

Entity Type: 16

CD Diagnostics has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include CD DIAGNOSTICS. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 1 (Chemicals) and Class 42 (Computer & Scientific). This trademark owner is based in Blue Bell, PA.

1620 Winchester Dr.

Blue Bell, PA 19422

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CD Diagnostics's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does CD Diagnostics have?

CD Diagnostics has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.

What trademark classes does CD Diagnostics file in?

CD Diagnostics files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are CD Diagnostics's most well-known trademarks?

CD Diagnostics's registered trademark portfolio includes well-known marks such as CD DIAGNOSTICS. These are among 1 currently registered trademark in the portfolio.

What is CD Diagnostics's trademark registration success rate?

CD Diagnostics has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.